2023 Pull-Through Infographic

For July’s Monthly Market Access Monday, The Kinetix Group (TKG) reviewed the impact of an effective pull-through (PT) approach. TKG’s most recent Payor Strategy Insights Panel revealed the need for greater success in PT planning and execution. Manufacturers encounter: – Misaligned internal and external stakeholder objectives– Confused HCPs– Disconnected analytics – Various views on real versus… Continue reading 2023 Pull-Through Infographic

NASHNET Presents Innovative White Paper on Utilizing Biomarkers to Diagnose and Stage NAFLD/NASH

NEW YORK, June 27, 2023 — NASHNET, a Kinetix Group network of excellence dedicated to advancing care pathways for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), announced the release of an innovative white paper. The paper is titled Biomarkers for Diagnosing and Staging Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Current Perspectives and Potential Future Applications.

2023 Market Access Agency Insights Survey Infographic

The Kinetix Group (TKG) recently conducted an inaugural survey, “Market Access Agency Insights.” 80% of respondents said their market access agency is either strategic or tactical but not both. In response, TKG announced Monthly Market Access Mondays, a series of posts that will provide key insights on specific market access topics and highlight how TKG’s… Continue reading 2023 Market Access Agency Insights Survey Infographic

The Kinetix Group Certified as a Most Loved Workplace®

NEW YORK, June 8, 2023 — The Kinetix Group (TKG) has been certified as a Most Loved Workplace®, which provides the most comprehensive review of workplace sentiment for organizations today. The certification comes just a few weeks after TKG announced its recertification as a Great Place To Work.

NASHNET Biomarkers White Paper

In support of the Global Liver Institute campaign for International NASH Day, NASHNET developed a groundbreaking white paper titled “Biomarkers for Diagnosing and Staging Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): Current Perspectives and Potential Future Applications.” The white paper sheds light on guideline-directed and optimal use of biomarkers to diagnose or stage NASH. Special thanks… Continue reading NASHNET Biomarkers White Paper

PHLN Spotlight #4: Hypertension Control Program with UnitedHealth Group

UnitedHealth Group developed a hypertension control program that leverages local health worker outreach and algorithmic, software-driven blood pressure management to help improve blood pressure control and address social determinants of health in specific communities. Special thanks to Jaime Murillo, MD for offering a deeper look into this innovative health model.  To learn more about Population Health Leaders Network (PHLN)… Continue reading PHLN Spotlight #4: Hypertension Control Program with UnitedHealth Group

The Kinetix Group Unveils Transformative Customer Engagement Platform for Life Science Companies

NEW YORK, June 6, 2023 —The Kinetix Group (TKG) announced the launch of TKG PACT, an insight-driven platform that helps life science companies transform how they engage with their customers. The multilayer platform leverages 25 years of insights and resources developed by TKG in its capacity as a full-service healthcare agency.